TMG — trimethylglycine, also called betaine — has become a standard companion to NMN in longevity supplement protocols. It appears alongside NMN in stack guides, in community discussions, and in the protocols of researchers and clinicians who follow this space closely. The reasoning behind the pairing is straightforward to state but worth examining carefully: NMN supplementation consumes methyl groups, and TMG replenishes them.
What is less often discussed is how strong the evidence for this concern actually is, whether everyone taking NMN needs to worry about it, and whether TMG is the right solution or simply the most convenient one. This article answers those questions directly.
What Is Methylation and Why Does It Matter?
Methylation is a biochemical process in which a methyl group — a carbon atom bonded to three hydrogen atoms (CH₃) — is transferred from one molecule to another. This transfer is one of the most fundamental reactions in biology, occurring billions of times per second across every cell in the body. Methylation reactions regulate gene expression through DNA methylation, synthesize neurotransmitters including dopamine and serotonin, process hormones and toxins in the liver, maintain the myelin sheath that insulates nerve cells, and produce creatine and phosphatidylcholine, among many other functions.
The universal methyl donor in human biology is SAM — S-adenosylmethionine. SAM is synthesized from the amino acid methionine and ATP, and it donates its methyl group to a wide range of biological targets before being converted to SAH (S-adenosylhomocysteine) and then to homocysteine. Homocysteine is either recycled back to methionine (requiring B12 and folate) or converted to cysteine (requiring B6). When methylation capacity is insufficient — due to poor diet, genetic variants in methylation enzymes, or excessive methyl demand — homocysteine accumulates, which is independently associated with cardiovascular disease, cognitive decline, and other adverse outcomes.
Healthy methylation is not a fringe concern. It is a foundational biochemical function, and its disruption has consequences across multiple organ systems.
Why NMN Supplementation Affects Methylation
The connection between NMN and methylation runs through the NAD+ biosynthesis pathway. When NMN is converted to NAD+ and subsequently metabolized, one of the breakdown products is nicotinamide — the base form of vitamin B3. Nicotinamide is cleared from the body primarily through a process called NNMT (nicotinamide N-methyltransferase)-mediated methylation, in which nicotinamide is methylated using a methyl group donated by SAM to form 1-methylnicotinamide, which is then excreted in urine.
At the doses of nicotinamide that circulate naturally, this methylation demand is modest and well within the body’s capacity. At supplemental doses of NMN — particularly at 500–1,000 mg/day — significantly more nicotinamide is produced and requires methylation for clearance. This elevated demand draws on the body’s SAM pool, which is the same pool feeding all the other methylation reactions described above.
Whether this constitutes a meaningful depletion of methylation capacity in practice depends on factors that vary between individuals: dietary methionine intake (methionine is the precursor to SAM), B vitamin status (B12 and folate are required for methionine recycling), genetic variants in methylation enzymes (MTHFR variants are common and reduce methylation efficiency), and the absolute dose of NMN being taken.
The theoretical concern is well-founded biochemically. The clinical evidence specifically documenting methylation depletion in humans taking supplemental NMN is not yet extensive — this is an area where the mechanistic logic has outrun the direct experimental confirmation in human trials. What evidence exists is largely indirect: elevated homocysteine as a marker of methylation insufficiency, and the known relationship between NAD+ metabolism and methyl group consumption.
What TMG Does and Why It Helps
TMG — trimethylglycine — is the most efficient methyl donor in the diet aside from SAM itself. Its name reflects its structure: glycine with three methyl groups attached. In the body, TMG donates one of those methyl groups to homocysteine, converting it to methionine via the BHMT (betaine-homocysteine methyltransferase) enzyme. This reaction simultaneously reduces homocysteine (a benefit in itself) and regenerates methionine, which can be converted back to SAM.
The practical effect is that TMG supplementation replenishes the methyl pool and supports the recycling of homocysteine to methionine — directly addressing both the depletion risk from NMN and one of its most measurable downstream consequences. TMG is found naturally in beets, spinach, quinoa, and wheat germ, but dietary amounts are typically 100–300 mg/day — well below the 500–2,000 mg/day supplemental doses used in protocols intended to support methylation under elevated demand.
TMG also functions as an osmolyte — it helps cells maintain their fluid balance under stress — and has independent evidence for modestly improving exercise performance and body composition, though these are secondary to the methylation support rationale in the longevity context.
Does Everyone Taking NMN Need TMG?
The honest answer is: probably not everyone, but the case for including it is strong enough that most people taking NMN at meaningful doses should consider it.
People for whom the methylation concern is most relevant:
- Those taking higher NMN doses (500 mg/day or above). The methyl demand from nicotinamide clearance scales with dose. At 250 mg/day, the concern is smaller; at 1,000 mg/day, it is more material.
- Those with MTHFR variants. Common variants in the MTHFR gene (particularly C677T and A1298C) reduce the efficiency of the folate-dependent pathway for recycling homocysteine. These individuals have a reduced methylation reserve and are more vulnerable to additional methyl demand. MTHFR variants are present in roughly 40–60% of the population in various forms, making this a broadly relevant consideration.
- Those with low dietary methionine intake. Methionine — the precursor to SAM — is found primarily in animal proteins. People eating low-protein or plant-heavy diets may have lower baseline SAM availability, making supplemental methyl support more valuable.
- Those with elevated baseline homocysteine. If a blood test shows homocysteine above the normal range (roughly 5–15 μmol/L), adding methyl support is rational regardless of NMN supplementation. In this population, TMG’s homocysteine-lowering effect is an independent benefit.
People for whom the concern is smaller:
- Those taking low NMN doses (250 mg/day or below), particularly if diet is nutrient-dense and protein-adequate.
- Those already supplementing with high-dose B vitamins (particularly methylfolate and methylcobalamin), which support the folate-dependent homocysteine recycling pathway independently.
- Those with confirmed normal or low homocysteine on recent bloodwork.
In practice, TMG is inexpensive, well-tolerated, and carries minimal downside risk for most people. Even for those in the lower-risk group, including it is a low-cost precaution that costs very little to maintain.
TMG vs. Other Methyl Donors
TMG is not the only way to support methylation. Other options are worth understanding, both to appreciate why TMG is generally preferred in this context and to recognize that some people may need a different or complementary approach.
Methylfolate and Methylcobalamin (Active B Vitamins)
The folate-dependent homocysteine recycling pathway requires 5-methyltetrahydrofolate (methylfolate) and methylcobalamin (active B12) as cofactors. People with MTHFR variants who do not efficiently convert folic acid to methylfolate benefit significantly from supplementing the active forms directly — methylfolate (not folic acid) and methylcobalamin (not cyanocobalamin). These address the enzyme-dependent recycling pathway rather than the direct methyl donation that TMG provides. For those with MTHFR variants, a combination of TMG and active B vitamins is often more appropriate than either alone.
SAMe (S-adenosylmethionine)
SAMe is the direct universal methyl donor and is available as a supplement. It is more expensive than TMG and less stable, degrading readily if not properly formulated. It is used therapeutically for depression and liver conditions. In the context of NMN supplementation support, TMG is the more practical and economical choice — it feeds into SAM production rather than bypassing the need for it, which is a more sustainable approach than supplementing SAMe directly.
Choline
Choline is an indirect methyl donor — it is converted to betaine (TMG) in the body, so choline-rich foods (eggs, liver) and choline supplements contribute to the methyl pool. For people who prefer food-based support, eating eggs regularly is a meaningful contribution. Supplemental choline (as choline bitartrate or alpha-GPC) can also contribute, though the conversion efficiency means that gram-for-gram, TMG provides more direct methyl support than choline.
How to Take NMN and TMG Together
The practical implementation is simple. TMG is typically taken at the same time as NMN — in the morning, with or without food. It is water-soluble and does not require fat for absorption. Powder forms are available and are cost-effective for higher doses; capsules are more convenient for lower doses.
Dosing guidance:
- At 250–500 mg/day NMN: 500–1,000 mg/day TMG
- At 500–1,000 mg/day NMN: 1,000–2,000 mg/day TMG
These ratios are derived from community practice and mechanistic reasoning rather than formal dose-finding studies — no clinical trial has established the optimal TMG:NMN ratio. They represent a reasonable and widely used starting point.
TMG can be split across morning and midday doses at higher amounts if GI discomfort occurs, though most people tolerate the full daily dose without issue. A fishy body odor — caused by excess trimethylamine production from TMG in some individuals with a specific gut microbiome configuration — is a known but uncommon side effect. If it occurs, reducing dose or splitting it more broadly across the day usually resolves it.
A Note on Monitoring
If you want objective confirmation that your methylation status is well-supported under NMN supplementation, a plasma homocysteine test is the most practical marker. It is available through standard blood panels and through direct-to-consumer testing. A level below 10 μmol/L is generally considered healthy; below 7–8 μmol/L is where most longevity-focused clinicians prefer to see it. Baseline testing before starting NMN and a follow-up test at three to six months provides useful information about whether the TMG dose is sufficient. If homocysteine is rising on NMN despite TMG supplementation, adding or increasing methylfolate and methylcobalamin is the next step.
Frequently Asked Questions
Can I get enough methyl support from diet alone without supplementing TMG?
Possibly, if your diet is consistently rich in methyl-supporting nutrients — adequate protein from animal sources (for methionine), eggs and liver (for choline), leafy greens (for folate), and B12 from animal products or supplementation. In practice, most people taking NMN at 500 mg/day or above are drawing on a methyl pool that dietary sources alone may not reliably replenish under that elevated demand. For people with MTHFR variants or borderline homocysteine, diet alone is even less likely to be sufficient.
Is there any downside to taking more TMG than needed?
TMG is well tolerated at typical supplemental doses. At very high doses (above 4–6 g/day), GI effects and the trimethylamine odor issue become more likely. Within the 500–2,000 mg/day range used alongside NMN, meaningful adverse effects are uncommon. There is a theoretical concern that excessive methyl donation could over-methylate DNA in certain contexts, but this risk is not established at typical supplemental doses and is unlikely to be practically relevant for the vast majority of users.
Should I take TMG if I’m taking NR instead of NMN?
The same methylation logic applies to NR. NR is also converted to NAD+ through the salvage pathway with nicotinamide as a breakdown product, generating the same methyl demand for clearance via NNMT. Whether NMN or NR produces more nicotinamide per dose at equivalent NAD+-raising amounts is not precisely characterized in human studies, but the mechanism is the same and the TMG pairing is equally rational for NR users.
Do I still need TMG if I’m already taking a B-complex supplement?
A B-complex supplement supports the folate-dependent homocysteine recycling pathway — a different but complementary route to methyl support. Whether it is sufficient depends on the forms used (methylfolate and methylcobalamin are more effective than folic acid and cyanocobalamin, particularly for MTHFR variant carriers) and the doses included. A standard B-complex may not provide enough active forms to fully offset elevated methyl demand from high-dose NMN. TMG addresses a different enzymatic pathway (BHMT rather than MS/MTHFR) and is genuinely complementary rather than redundant to B vitamin support.